Who owns VAXXINITY CL A ORD?
- Ticker: VAXX
- CUSIP Number: 92244v104
Tip: Access positions for across all investors
Analyze quarterly positions in Vaxxinity Cl A Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vaxxinity Cl A Ord stock
Who bought or sold VAXXINITY CL A ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 3.0M | $2.2M | 0% | Mar 2024 |
|
| BlackRock | 2.6M | $1.9M | 4% | Mar 2024 |
|
| Vanguard Group | 2.4M | $1.7M | 1% | Mar 2024 |
|
| Geode Capital Management | 879k | $630k | 6% | Mar 2024 |
|
| Northern Trust | 333k | $239k | -5% | Mar 2024 |
|
| Creative Planning | 287k | $206k | 1% | Mar 2024 |
|
| Bridgeway Capital Management | 229k | $164k | 208% | Mar 2024 |
|
| Pathstone Holdings | 154k | $110k | 0% | Mar 2024 |
|
| Stelac Advisory Services | 140k | $101k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 120k | $86k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 110k | $79k | -9% | Mar 2024 |
|
| Bank of America Corporation | 92k | $66k | -74% | Mar 2024 |
|
| Ieq Capital | 83k | $60k | 0% | Mar 2024 |
|
| McAdam | 78k | $56k | 0% | Mar 2024 |
|
| Morgan Stanley | 62k | $45k | 71% | Mar 2024 |
|
| Nuveen Asset Management | 58k | $42k | 0% | Mar 2024 |
|
| Millennium Management | 48k | $35k | 12% | Mar 2024 |
|
| Jpmorgan Chase & Co | 45k | $32k | 61% | Mar 2024 |
|
| Rhumbline Advisers | 45k | $32k | 14% | Mar 2024 |
|
| UBS Group | 43k | $31k | -1% | Mar 2024 |
|
| Lincoln National | 41k | $30k | 0% | Mar 2024 |
|
| Blue Zone Wealth Advisors | 41k | $29k | 0% | Mar 2024 |
|
| Toroso Investments | 33k | $23k | 100% | Mar 2024 |
|
| Barclays | 30k | $21k | -49% | Mar 2024 |
|
| Titleist Asset Management | 28k | $20k | 0% | Mar 2024 |
|
| New York State Common Retirement Fund | 24k | $17k | 0% | Mar 2024 |
|
| American International | 21k | $18k | 0% | Dec 2023 |
|
| Branch Banking & Trust Company | 21k | $15k | 0% | Mar 2024 |
|
| Clarius | 20k | $14k | 0% | Mar 2024 |
|
| Wedbush Morgan Securities | 20k | $17k | 0% | Dec 2023 |
|
| Glenmede Trust Company | 19k | $14k | 100% | Mar 2024 |
|
| XTX Topco | 19k | $14k | 100% | Mar 2024 |
|
| HighTower Advisors | 17k | $13k | -22% | Mar 2024 |
|
| Three Bridge Wealth Advisors | 14k | $10k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 13k | $9.1k | 15% | Mar 2024 |
|
| Tower Research Capital | 13k | $9.1k | 26% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 12k | $9.0k | 0% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 11k | $8.0k | -40% | Mar 2024 |
|
| Integrated Wealth Concepts | 11k | $7.9k | 0% | Mar 2024 |
|
| Spire Wealth Management | 9.0k | $6.5k | -53% | Mar 2024 |
|
| FMR | 8.4k | $6.0k | 686% | Mar 2024 |
|
| Advisor Group Holdings | 7.6k | $5.5k | 0% | Mar 2024 |
|
| Citigroup | 7.1k | $5.1k | 17% | Mar 2024 |
|
| Legal & General Group | 5.3k | $3.8k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 4.8k | $3.5k | -49% | Mar 2024 |
|
| Summit Investment Advisors | 3.5k | $2.5k | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 2.1k | $1.5k | 0% | Mar 2024 |
|
| Amalgamated Bank | 1.4k | $1.0k | -76% | Mar 2024 |
|
| Royal Bank of Canada | 974.00 | $0 | -93% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 825.00 | $592.020000 | 100% | Mar 2024 |
|
| Eagle Bay Advisors | 708.00 | $507.990000 | 0% | Mar 2024 |
|
| Sandy Spring Bank | 100.00 | $72.000000 | 0% | Mar 2024 |
|
| Capital Advisors | 62.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Vaxxinity Cl A Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 79k | $68k |
| Hollencrest Securities | Dec 2023 | 20k | $17k |
| Two Sigma Securities | Dec 2023 | 12k | $9.9k |
| Florida State Board of Administration | Dec 2023 | 11k | $9.4k |
| Glassman Wealth Services | Dec 2023 | 2.4k | $2.0k |
| Advisory Services Network | Dec 2023 | 600.00 | $510.000000 |